Frank Barletta

1.9k total citations
18 papers, 1.1k citations indexed

About

Frank Barletta is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Frank Barletta has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Frank Barletta's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (9 papers) and Vitamin D Research Studies (5 papers). Frank Barletta is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (9 papers) and Vitamin D Research Studies (5 papers). Frank Barletta collaborates with scholars based in United States, Netherlands and Switzerland. Frank Barletta's co-authors include Sylvia Christakos, Tracey Clark, Xiaogang Han, L. Nathan Tumey, Puneet Dhawan, Mihali Raval-Pandya, Benita S. Katzenellenbogen, Boris J. Cheskis, Barry S. Komm and Leonard P. Freedman and has published in prestigious journals such as Analytical Chemistry, Clinical Cancer Research and Endocrinology.

In The Last Decade

Frank Barletta

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Frank Barletta

Since Specialization

Citations

This map shows the geographic impact of Frank Barletta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Barletta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Barletta more than expected).

Fields of papers citing papers by Frank Barletta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Barletta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Barletta. The network helps show where Frank Barletta may publish in the future.

Co-authorship network of co-authors of Frank Barletta

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Barletta. A scholar is included among the top collaborators of Frank Barletta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Barletta. Frank Barletta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective 2021 ·Clinical Pharmacology & Therapeutics ·Chunze Li, Rajeev Menon, Markus Walles, Renu Singh, Vijay Upreti, Deanna J. Brackman, Anthony Lee, Christopher J. Endres, (unknown), Donglu Zhang, Frank Barletta, Ajit Suri, Dominik Hainzl, Ken Liao, Bojan Lalovic, Maribel Beaumont, Peiying Zuo, (unknown), Wei Dong	12
2	Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1 2020 ·Journal of Pharmacokinetics and Pharmacodynamics ·Alison Betts, Tracey Clark, Paul Jasper, John Tolsma, Piet H. van der Graaf, Edmund I. Graziani, Edward Rosfjord, Matthew Sung, Dangshe Ma, Frank Barletta	19
3	Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors 2019 ·Clinical Cancer Research ·Changhua Ji, Marc D. Roy, Jonathan Golas, Allison Vitsky, Sripad Ram, Steven W. Kumpf, Matthew T. Martin, Frank Barletta, William A. Meier, Andrea T. Hooper, Puja Sapra, Nasir Khan, Martin B. Finkelstein, Magali Guffroy, Bernard S. Buetow	91
4	A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART® 2019 ·The AAPS Journal ·Alison Betts, Nahor Haddish‐Berhane, Dhaval K. Shah, Piet H. van der Graaf, Frank Barletta, Lindsay King, Tracey Clark, Cris Kamperschroer, Adam Root, Andrea T. Hooper, Xiaoying Chen	54
5	Establishing in vitro–in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approach 2018 ·Journal of Pharmacokinetics and Pharmacodynamics ·Dhaval K. Shah, Frank Loganzo, Nahor Haddish‐Berhane, Sylvia Musto, (unknown), Frank Barletta, Judy Lucas, Tracey Clark, (unknown), Alison Betts	17
6	Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates 2017 ·The AAPS Journal ·L. Nathan Tumey, Fengping Li, Brian Rago, Xiaogang Han, Frank Loganzo, Sylvia Musto, Edmund I. Graziani, Sujiet Puthenveetil, Jeffrey Casavant, Kimberly Marquette, Tracey Clark, Jack Bikker, Eric M. Bennett, Frank Barletta, Nicole Piche‐Nicholas, Amy Tam, Christopher J. O’Donnell, Hans Peter Gerber, Lioudmila Tchistiakova	48
7	Quantitative Conjugated Payload Measurement Using Enzymatic Release of Antibody–Drug Conjugate with Cleavable Linker 2017 ·Bioconjugate Chemistry ·Brian Rago, L. Nathan Tumey, Cong Wei, Frank Barletta, Tracey Clark, Steven Hansel, Xiaogang Han	26
8	Where Did the Linker-Payload Go? A Quantitative Investigation on the Destination of the Released Linker-Payload from an Antibody-Drug Conjugate with a Maleimide Linker in Plasma 2016 ·Analytical Chemistry ·Cong Wei, Guodong Zhang, Tracey Clark, Frank Barletta, L. Nathan Tumey, Brian Rago, Steven Hansel, Xiaogang Han	68
9	Calculated Conjugated Payload from Immunoassay and LC–MS Intact Protein Analysis Measurements of Antibody-Drug Conjugate 2016 ·Bioanalysis ·Brian Rago, Tracey Clark, Lindsay King, Jenny Zhang, L. Nathan Tumey, Fengping Li, Frank Barletta, Cong Wei, Mauricio Leal, (unknown), Xiaogang Han	21
10	Mechanistic Projection of First‐in‐Human Dose for Bispecific Immunomodulatory P‐Cadherin LP‐DART: An Integrated PK/PD Modeling Approach 2016 ·Clinical Pharmacology & Therapeutics ·Xiaohong Chen, Nahor Haddish‐Berhane, Paul A. Moore, (unknown), Yanqi Yang, (unknown), Dawei Xuan, Hugh A. Barton, (unknown), Frank Barletta	32
11	Unconjugated Payload Quantification and Dar Characterization of Antibody–Drug Conjugates Using High-Resolution MS 2016 ·Bioanalysis ·(unknown), Cong Wei, Ragu Ramanathan, Frank Barletta, Rick C. Steenwyk, (unknown)	26
12	Mild Method for Succinimide Hydrolysis on ADCs: Impact on ADC Potency, Stability, Exposure, and Efficacy 2014 ·Bioconjugate Chemistry ·L. Nathan Tumey, Manoj B. Charati, Tao He, Eric Sousa, Dangshe Ma, Xiaogang Han, Tracey Clark, (unknown), Frank Loganzo, Frank Barletta, Judy Lucas, Edmund I. Graziani	146
13	Characterization of the Interactions of Estrogen Receptor and MNAR in the Activation of cSrc 2004 ·Molecular Endocrinology ·Frank Barletta, (unknown), (unknown), Barry S. Komm, Benita S. Katzenellenbogen, Boris J. Cheskis	138
14	Integration of hormone signaling in the regulation of human 25(OH)D₃24-hydroxylase transcription 2004 ·American Journal of Physiology-Endocrinology and Metabolism ·Frank Barletta, Puneet Dhawan, Sylvia Christakos	29
15	Vitamin D target proteins: Function and regulation 2003 ·Journal of Cellular Biochemistry ·Sylvia Christakos, Frank Barletta, (unknown), Puneet Dhawan, Y. Liu, Angela Porta, Xiaorong Peng	85
16	Enhancement of VDR-Mediated Transcription by Phosphorylation: Correlation with Increased Interaction Between the VDR and DRIP205, a Subunit of the VDR-Interacting Protein Coactivator Complex 2002 ·Molecular Endocrinology ·Frank Barletta, Leonard P. Freedman, Sylvia Christakos	59
17	YY1 Represses Vitamin D Receptor-Mediated 25-Hydroxyvitamin D3 24-Hydroxylase Transcription: Relief of Repression by CREB-Binding Protein 2001 ·Molecular Endocrinology ·Mihali Raval-Pandya, Puneet Dhawan, Frank Barletta, Sylvia Christakos	24
18	Deficient Mineralization of Intramembranous Bone in Vitamin D-24-Hydroxylase-Ablated Mice Is Due to Elevated 1,25-Dihydroxyvitamin D and Not to the Absence of 24,25-Dihydroxyvitamin D* 2000 ·Endocrinology ·René St‐Arnaud, Alice Arabian, Rose Travers, Frank Barletta, Mihali Raval-Pandya, (unknown), Jos Depovere, Chantal Mathieu, Sylvia Christakos, Marie B. Demay, Francis H. Glorieux	211

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact